Peptide Hubs
GONADORELIN 10 MG
CLASSIFICATION: GONADOTROPIN-RELEASING HORMONE (GNRH) ANALOG
ACTIVE SUBSTANCE: GONADORELIN
FORM: LYOPHILIZED POWDER (2 ML VIAL x 10 MG)
ACTIVE HALF-LIFE: 2–4 MINUTES
DOSAGE: 100–500 MCG PER DOSE (RESEARCH USE)
ACNE: UNLIKELY
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NONE
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
Out of stock
Gonadorelin 10 mg – Peptide Hubs
Gonadorelin is a synthetic analog of natural gonadotropin-releasing hormone (GnRH), used in research to stimulate the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the anterior pituitary. The 10 mg lyophilized format by Peptide Hubs is designed for precise hormonal research involving fertility, testosterone regulation, and hypothalamic-pituitary-gonadal (HPG) axis function.
Mechanism of Action
Gonadorelin binds to GnRH receptors in the pituitary gland, leading to an acute surge in LH and FSH. This in turn stimulates the gonads to produce testosterone or estrogen depending on the sex of the model organism. It is often used to evaluate fertility function, testicular recovery, and feedback mechanisms. Gonadorelin is also explored in studies related to hypogonadism and HCG/LH synergy. See this NCBI resource on Gonadorelin pharmacology.
Primary Research Applications
- Stimulation of LH and FSH release in HPG axis models
- Investigation of fertility and testosterone recovery
- Evaluation of hypothalamic or pituitary function
- Comparative studies with HCG or Clomiphene Citrate
Gonadorelin may be stacked with HCG 2500 IU or Clomiphene Citrate for post-cycle therapy (PCT) studies or testosterone reactivation protocols. It can also be used in cycles evaluating the impact of androgens on fertility markers when used alongside compounds like GHRP-6 or DSIP.
Suggested Experimental Use
- Dosage: 100–500 mcg per dose in single or pulsatile protocols
- Administration: Subcutaneous or intravenous injection
- Cycle Duration: Short-term stimulation (1–14 days typical in models)
Stacking Options
- GHRP-2 – for synergy in GH + LH/FSH pulse studies
- Chonluten – to study hormone–immune axis balance
- AOD 9604 – to explore gonadal recovery and fat regulation
- GHK Basic – for testicular support and recovery analysis
Safety & Legal Status
Gonadorelin 10 mg is intended strictly for **research purposes only**. It is not approved for medical use and must not be used in humans outside controlled lab environments. No aromatization, liver toxicity, or androgenic activity is reported. Short half-life may require frequent dosing in research protocols. For ongoing studies, visit ClinicalTrials.gov.
Frequently Asked Questions
What is Gonadorelin used for in research?
Gonadorelin is used to stimulate the release of LH and FSH from the pituitary in order to study fertility, testosterone recovery, and hypothalamic feedback systems.
Is Gonadorelin similar to HCG?
While both stimulate testosterone production, Gonadorelin acts on the pituitary to release LH/FSH, whereas HCG mimics LH directly at the gonadal level.
How long does Gonadorelin stay active?
Its half-life is very short (2–4 minutes), so it may require repeated or pulsatile dosing in research settings to maintain LH/FSH stimulation.
Can Gonadorelin be used in PCT studies?
Yes, Gonadorelin is frequently used in post-cycle therapy research to restore endogenous testosterone production via LH/FSH reactivation.
No reviews found
Please log in to write GONADORELIN 10 MG review.